
Sign up to save your podcasts
Or


In this episode, you’ll hear from ASHI President Dr. William Hildebrand as he discusses his career path to HLA, his goals for the Society, and the additional directions in HLA including immuno-oncology, autoimmune therapies and infectious disease.
By American Society for Histocompatibility & Immunogenetics4.8
1616 ratings
In this episode, you’ll hear from ASHI President Dr. William Hildebrand as he discusses his career path to HLA, his goals for the Society, and the additional directions in HLA including immuno-oncology, autoimmune therapies and infectious disease.

369,741 Listeners

48 Listeners